Vrije Universiteit Brussel

 

Publications on Thrombophilia

  • Identification of two de novo mutations responsible for type I antithrombin deficiency.
    Orlando C, Lissens W, Hasaerts D, Jochmans K.
    Thromb Haemost. - 2012 - 107(1):187-9

  • Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine
    De Smet D, Jochmans K, Neyns B.
    Ann Hematol. - 2008 - 87(6):495-6

  • Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.
    Ghys T, Achtergael W, Verschraegen I, Leus B, Jochmans K.
    Thromb Res. - 2008 - 121(6):735-41

  • Successful outcome in a pregnant woman with homozygous antithrombin deficiency
    Alguel G, Jochmans K, Simanek R, Ay C, Quehenberger P, Langer M, Pabinger I.
    Thromb Haemost. - 2007 - 98(6):1377-8

  • Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation.
    Kuhli C, Jochmans K, Scharrer I, Lüchtenberg M, Hattenbach LO.
    Arch Ophthalmol. - 2006 - 124(8):1165-9

  • Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer
    Caers J, Reekmans A, Jochmans K, Naegels S, Mana F, Urbain D, Reynaert H.
    Endoscopy - 2003 - 35(6):542-4

  • Plasma D-dimer concentrations in different clinical conditions
    Ver Elst K, Jochmans K, De Pauw A, De Waele M.
    Acta Clin Belg - 2002 - 57(6):325-30

  • Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis.
    Maes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K.
    J Neurol Neurosurg Psychiatry - 2002 - 73(4):458

  • Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism
    Kuhle S, Lane DA, Jochmanns K, Male C, Quehenberger P, Lechner K, Pabinger I.
    Thromb Haemost. - 2001 - 86(4):1007-11.

  • Antithrombin deficiency and thrombosis in a young child
    Kok V, Slacmeulder M, Jochmans K, Ninane J.
    Arch Pediatr. - 1999 - 6(3):279-82

  • The molecular basis of antithrombin deficiency in Belgian and Dutch families.
    Jochmans K, Lissens W, Seneca S, Capel P, Chatelain B, Meeus P, Osselaer JC, Peerlinck K, Seghers J, Slacmeulder M, Stibbe J, van de Loo J, Vermylen J, Liebaers I, De Waele M.
    Thromb Haemost. - 1998 - 80(3):376-81

  • Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Lane DA, Bayston T, Olds RJ, Fitches AC, Cooper DN, Millar DS, Jochmans K, Perry DJ, Okajima K, Thein SL, Emmerich J.
    Thromb Haemost. - 1997 - 77(1):197-211

  • Nonsense mutation Arg197stop in a Dutch family with type 1 hereditary antithrombin (AT) deficiency causing thrombophilia
    Michiels JJ, van der Luit L, van Vliet HH, Jochmans K, Lissens W.
    Thromb Res - 1995 - 78(3):251-4

  • Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis
    Jochmans K, Lissens W, Vervoort R, Peeters S, De Waele M, Liebaers I
    Blood - 1994 - 83(1):146-51

  • Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation
    Jochmans K, Lissens W, Yin T, Michiels JJ, van der Luit L, Peerlinck K, De Waele M, Liebaers I.
    Blood - 1994 - 84(11):3742-8

  • Myocardial infarction in a neonate with hereditary antithrombin III deficiency
    Peeters S, Vandenplas Y, Jochmans K, Bougatef A, De Waele M, De Wolf D
    Acta Paediatr - 1993 - 82(6-7):610-3

 

Back to top

  ©2004-2012 • HEIM • Vrije Universiteit Brussel • Faculteit Geneeskunde & Farmacie • Laarbeeklaan 103 • 1090 Jette • Tel.: (+32)-(0)2-477.44.06 • heim@vub.ac.be